Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study

BackgroundData on off-label reduced dose risk among patients with atrial fibrillation (AF) who qualify for a single-dose reduction of apixaban is scarce.ObjectivesWe prospectively assessed apixaban dosing and clinical characteristics in AF patients meeting a dose reduction criterion.MethodsThe multi...

Full description

Bibliographic Details
Main Authors: JungMin Choi, So-Ryoung Lee, Soonil Kwon, Hyo-Jeong Ahn, Kyung-Yeon Lee, Jong-Sung Park, Jong-Il Choi, Sung Ho Lee, Jung Ho Heo, Il-Young Oh, Young Keun On, Hee Tae Yu, Kwang-No Lee, Nam-Ho Kim, Hyung Wook Park, Ki Hong Lee, Seung Yong Shin, Seil Oh, Gregory Y. H. Lip, Seongwook Han, Eue-Keun Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
apixaban
atrial fibrillation
dose
clinical characteristics
off-label reduced dose
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1367623/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1367623/full

Similar Items